Focus: Eclipse Regenesis is a biotechnology company focused on developing a tissue-growing device for Short Bowel Syndrome, a rare gastrointestinal condition. The company is based in Mountain View, CA and operates in the specialized medical device/biotech intersection.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Eclipse Regenesis is a speculative early-stage bet suitable only for risk-tolerant candidates seeking deep technical involvement in rare-disease innovation with uncertain near-term career stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Eclipse Regenesis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Eclipse Regenesis's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo